TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24559812

Group type: EXPERIMENTAL
Intervention: Auricular acupuncture with electrical stimulation (verum group, n=28)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo treatment with a P-Stim® dummy (placebo group, n=28)
Number of subjects: 56
Study: 22647517

Group type: EXPERIMENTAL
Intervention: Phlebotomy (n = 33)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (n = 31)
Number of subjects: 64
Study: 20621734

Group type: EXPERIMENTAL
Intervention: Erlotinib (EGFR tyrosine kinase inhibitor)
Number of subjects: 23
Study: 16996172

Group type: EXPERIMENTAL
Intervention: Peru-15 vaccine (2x10^8 cfu)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Peru-15 vaccine (2x10^7 cfu)
Number of subjects: 240
Study: 16358380

Group type: EXPERIMENTAL
Intervention: Low-dosage levothyroxine (L-T4) at an initial dosage of 3.21-5.81 microg/(kg.d), average of 16.25±3.87 microg/d, for a mean duration of therapy of 28.09±9.56 months.
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group of 29 healthy peers.
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Follow-up evaluations including TT3, TT4, TSH serum levels, thyroid gland morphology, bone age, growth development, and DQ.
Number of subjects: 57
Study: 11528582

Group type: EXPERIMENTAL
Intervention: Fluconazole (200 mg/week)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9780524

Group type: EXPERIMENTAL
Intervention: Direct hypnotic suggestions (Harvard Group Scale of Hypnotizability)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Indirect hypnotic suggestions (Alman Wexler Indirect Hypnotic Susceptibility Scale)
Number of subjects: 0
Study: 8169385

Group type: EXPERIMENTAL
Intervention: Glucocorticoids
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 3215160

Group type: EXPERIMENTAL
Intervention: Weight gain prevention treatment (monthly newsletters, financial incentives, optional education course)
Number of subjects: 219

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 219
Study: 31172827

Group type: EXPERIMENTAL
Intervention: NO3‐‐rich beetroot juice (BJ)
Number of subjects: 15

Group type: COMPARATOR
Intervention: NO3‐‐depleted (placebo) beetroot juice
Number of subjects: 15
Study: 28719151

Group type: EXPERIMENTAL
Intervention: Support and Problem Solving (SPS) for 1.5 months
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Case Management for 4.5 months
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Case Management + Antidepressant Medication for 6 months
Number of subjects: 500

Group type: COMPARATOR
Intervention: Cognitive Behavioural Case Management + Placebo for 6 months
Number of subjects: 500
Study: 28623969

Group type: EXPERIMENTAL
Intervention: Preterm delivery and term delivery after suspected preterm labour
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Placental samples from preterm and term deliveries after suspected preterm labour
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Suspected preterm labour
Number of subjects: 132

Group type: COMPARATOR
Intervention: Term delivery without suspected preterm labour
Number of subjects: 132
Study: 26200520

Group type: EXPERIMENTAL
Intervention: Sleep intervention program (details not specified)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Objective sleep measures (total sleep time, total numbers of awakenings, total wake time)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Participant characteristics (marital status, use of sleep medication, comorbidity, posttraumatic stress disorder, living arrangement)
Number of subjects: 50
Study: 23998400

Group type: EXPERIMENTAL
Intervention: Segmentectomy
Number of subjects: 210

Group type: COMPARATOR
Intervention: Wedge resection
Number of subjects: 210
Study: 20938664

Group type: EXPERIMENTAL
Intervention: Fulvestrant 250 mg/month
Number of subjects: 234

Group type: COMPARATOR
Intervention: Anastrozole 1 mg/day
Number of subjects: 234
Study: 18394217

Group type: EXPERIMENTAL
Intervention: Low-frequency (two) meal ingestion (LOFREQ(MEAL))
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: High-frequency (twelve) meal ingestion (HIFREQ(MEAL))
Number of subjects: 5

Group type: COMPARATOR
Intervention: Fasting (FAST)
Number of subjects: 5
Study: 16798391

Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin-piperaquine (6.3/50 mg/kg)
Number of subjects: 652

Group type: COMPARATOR
Intervention: Artesunate-mefloquine (12/25 mg/kg)
Number of subjects: 652

Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin-piperaquine
Number of subjects: 652

Group type: COMPARATOR
Intervention: Artesunate-mefloquine
Number of subjects: 652
Study: 12824948

Group type: EXPERIMENTAL
Intervention: Aspirin (80 mg per day)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (no aspirin)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Recurrent abortions (IgGacl positive)
Number of subjects: 60
Study: 11070146

Group type: EXPERIMENTAL
Intervention: Fish oil (1.5 g)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Corn oil (4.5 g)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sesame oil (4.5 g)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 9007920

Group type: EXPERIMENTAL
Intervention: 2% lidocaine with 1:100,000 epinephrine
Number of subjects: 42

Group type: COMPARATOR
Intervention: 3% mepivacaine
Number of subjects: 42
Study: 8284243

Group type: EXPERIMENTAL
Intervention: Streptokinase plus heparin
Number of subjects: 91

Group type: COMPARATOR
Intervention: Heparin therapy alone
Number of subjects: 91
Study: 3693584

Group type: EXPERIMENTAL
Intervention: Fasted state
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Fed state
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (Fasted state)
Number of subjects: 12
Study: 30741894

Group type: COMPARATOR
Intervention: Combination treatment (steroids and diuretics simultaneously for 2 weeks)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Sequential treatment (diuretics for 2 weeks followed by steroids for another 2 weeks if no response)
Number of subjects: 92
Study: 28137247

Group type: EXPERIMENTAL
Intervention: Dietary support group
Number of subjects: 67

Group type: COMPARATOR
Intervention: Social support control group
Number of subjects: 67
Study: 26510135

Group type: EXPERIMENTAL
Intervention: School-based multi-component lifestyle intervention program (classroom curriculum, school environment support, family involvement, fun programs/events) for 1 year
Number of subjects: 1182

Group type: EXPERIMENTAL
Intervention: School-based multi-component lifestyle intervention program
Number of subjects: 1182
Study: 23433403

Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg/d
Number of subjects: 22

Group type: COMPARATOR
Intervention: Atorvastatin 10 mg/d
Number of subjects: 22
Study: 21875858

Group type: EXPERIMENTAL
Intervention: Ivabradine
Number of subjects: 411

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 411
Study: 19724191

Group type: EXPERIMENTAL
Intervention: Darunavir/ritonavir (DRV/r)
Number of subjects: 80
Study: 17372320

Group type: EXPERIMENTAL
Intervention: Physical Activity Program (80 minutes of PA offered 5 days/week for 10 months)
Number of subjects: 136
Study: 15007086

Group type: EXPERIMENTAL
Intervention: Computed Tomography (CT)
Number of subjects: 530

Group type: EXPERIMENTAL
Intervention: Carcino-embryonic antigen (CEA)
Number of subjects: 530

Group type: COMPARATOR
Intervention: Symptomatic detection
Number of subjects: 530

Group type: EXPERIMENTAL
Intervention: CT and CEA combined
Number of subjects: 530
Study: 12469051

Group type: EXPERIMENTAL
Intervention: Aspirin and warfarin therapy
Number of subjects: 244

Group type: COMPARATOR
Intervention: Aspirin therapy
Number of subjects: 244
Study: 9846593

Group type: EXPERIMENTAL
Intervention: Caffeine ingestion (5 mg/kg fat-free mass)
Number of subjects: 20
Study: 8137114

Group type: EXPERIMENTAL
Intervention: mianserin (antidepressant)
Number of subjects: 50
Study: 2512256

Group type: EXPERIMENTAL
Intervention: Immediate ibuprofen (2400 mg/day)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Placebo medication for 48 h, followed by ibuprofen (2400 mg/day) from the 3rd day onwards
Number of subjects: 122
Study: 1150903

Group type: EXPERIMENTAL
Intervention: Indomethacin administered concurrently with warfarin for five days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single oral dose of warfarin administered before and after ten consecutive days of oral indomethacin administration
Number of subjects: 0
Study: 480048

Group type: EXPERIMENTAL
Intervention: Naproxen 2.5 mg/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Naproxen 7.5 mg/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aspirin 15 mg/kg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31735246

Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Therapy (CBT)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 111
Study: 28292751

Group type: EXPERIMENTAL
Intervention: Catheter ablation plus ICD implantation
Number of subjects: 111

Group type: COMPARATOR
Intervention: ICD implantation without catheter ablation (ICD-only group)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Catheter ablation
Number of subjects: 111
Study: 26460992

Group type: EXPERIMENTAL
Intervention: Radiation therapy (RT) or chemoradiation (CRT)
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Mean dose to the oral mucosa
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Concomitant chemotherapy
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Mean dose to the inferior constrictor (IC)
Number of subjects: 253
Study: 23652274

Group type: EXPERIMENTAL
Intervention: Intermittent hypoxic training prior to strength-endurance exercise program
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group with placebo air mixture
Number of subjects: 34
Study: 21283158

Group type: EXPERIMENTAL
Intervention: High-density silicone oil (HDSO) as an internal retinal tamponade after vitrectomy
Number of subjects: 41
Study: 18957534

Group type: EXPERIMENTAL
Intervention: High-monounsaturated fatty acid (MUFA) diet
Number of subjects: 124

Group type: COMPARATOR
Intervention: High-carbohydrate (CHO) diet
Number of subjects: 124
Study: 17916877

Group type: COMPARATOR
Intervention: 10 mg metoclopramide as a slow intravenous infusion over 15 min (SIG group)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 10 mg metoclopramide intravenous bolus infusion over 2 min (BIG group)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Both groups (SIG and BIG)
Number of subjects: 120
Study: 16026005

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide
Number of subjects: 35
Study: 11982466

Group type: EXPERIMENTAL
Intervention: Sentinel lymph node biopsy guided by preoperative lymphoscintigraphy
Number of subjects: 2000
Study: 9619011

Group type: EXPERIMENTAL
Intervention: Continuous warm blood cardioplegia with normothermic CPB
Number of subjects: 20

Group type: COMPARATOR
Intervention: Intermittent perfusion of cold crystalloid (St. Thomas Hospital solution) with hypothermic CPB
Number of subjects: 20
Study: 7713856

Group type: EXPERIMENTAL
Intervention: Amantadine 100 mg b.i.d.
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Biperiden 2 mg b.i.d.
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 2502974

Group type: EXPERIMENTAL
Intervention: Valproic acid rectal suppository (500 mg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Oral valproate sodium syrup (500 mg)
Number of subjects: 6
Study: 776351

Group type: COMPARATOR
Intervention: Propranolol 60 mg/day
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Propranolol 120 mg/day
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Propranolol 240 mg/day
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 30431297

Group type: EXPERIMENTAL
Intervention: Cognitive Therapy (CT)
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Cognitive Therapy (MBCT)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Cognitive Therapy (CT) and Mindfulness-Based Cognitive Therapy (MBCT)
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Practice of therapy-acquired regulatory skills
Number of subjects: 166
Study: 28831733

Group type: EXPERIMENTAL
Intervention: Pre-surgical pulmonary rehabilitation (PR) program (exercise, diet, and psychological intervention) for 12 weeks
Number of subjects: 4

Group type: COMPARATOR
Intervention: Bariatric surgery only (Control group)
Number of subjects: 4
Study: 25139056

Group type: EXPERIMENTAL
Intervention: MTAU plus five sessions of graded body image exposure
Number of subjects: 45

Group type: COMPARATOR
Intervention: Maintenance treatment as usual (MTAU) only
Number of subjects: 45
Study: 23746555

Group type: EXPERIMENTAL
Intervention: Liraglutide 1.8mg added to metformin followed by insulin detemir for 52 weeks (RT group)
Number of subjects: 323

Group type: COMPARATOR
Intervention: Continuation without detemir (RC group)
Number of subjects: 323

Group type: EXPERIMENTAL
Intervention: Run-in phase with liraglutide and metformin
Number of subjects: 323
Study: 21666744

Group type: EXPERIMENTAL
Intervention: Chlorproguanil-dapsone (CD)
Number of subjects: 1238

Group type: COMPARATOR
Intervention: Artemether-lumefantrine (AL)
Number of subjects: 1238
Study: 19927363

Group type: EXPERIMENTAL
Intervention: Immunoadsorption apheresis (IA) plus immunosuppressive drug therapy (IDT)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Immunosuppressive drug therapy (IDT) only
Number of subjects: 17
Study: 16796126

Group type: EXPERIMENTAL
Intervention: Vaginosacral colpopexy (VSC)
Number of subjects: 32
Study: 15164115

Group type: EXPERIMENTAL
Intervention: Nutritional status evaluation using anthropometry (height, weight, hemoglobin concentration)
Number of subjects: 1655

Group type: EXPERIMENTAL
Intervention: Rural children
Number of subjects: 1655

Group type: EXPERIMENTAL
Intervention: Urban children
Number of subjects: 1655

Group type: EXPERIMENTAL
Intervention: Hemoglobin concentration measurement
Number of subjects: 1655
Study: 12368620

Group type: EXPERIMENTAL
Intervention: Bipolar radiofrequency thermal ablation of inferior turbinates at 100 kHz with a voltage root mean square value of 168 to 182
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Bipolar radiofrequency thermal ablation of inferior turbinates
Number of subjects: 20
Study: 9445274

Group type: EXPERIMENTAL
Intervention: T-piece trial (T)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Extubation (E)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Endotracheal tube (ETT)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Supraglottic airway
Number of subjects: 14
Study: 8077353

Group type: EXPERIMENTAL
Intervention: Evening calcium supplementation (1000 mg for 14 days)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Morning calcium supplementation (1000 mg for 14 days)
Number of subjects: 18
Study: 2807562

Group type: EXPERIMENTAL
Intervention: Enoxacin 400 mg administered one hour before ESWL
Number of subjects: 50

Group type: COMPARATOR
Intervention: No antibiotic (control group)
Number of subjects: 50
Study: 773588

Group type: EXPERIMENTAL
Intervention: Halofenate
Number of subjects: 4

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study: 31977000

Group type: EXPERIMENTAL
Intervention: AB002 (E‐WE thrombin), <2 µg/kg, IV
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AB002 (E‐WE thrombin)
Number of subjects: 0
Study: 31609396

Group type: EXPERIMENTAL
Intervention: Switching to another SSRI or to venlafaxine with cognitive behavioral therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Switching to another SSRI or to venlafaxine without cognitive behavioral therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 29846417

Group type: EXPERIMENTAL
Intervention: Topical anesthesia
Number of subjects: 69

Group type: COMPARATOR
Intervention: Retrobulbar anesthesia
Number of subjects: 69
Study: 26053011

Group type: EXPERIMENTAL
Intervention: CONTOUR PLUS BGMS for fingertip blood tests
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: CONTOUR PLUS BGMS for venous blood tests
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: CONTOUR PLUS BGMS for precision testing
Number of subjects: 363
Study: 25267568

Group type: EXPERIMENTAL
Intervention: Routine EEG
Number of subjects: 399
Study: 23290112

Group type: EXPERIMENTAL
Intervention: 3-month neoadjuvant hormonal therapy (NHT) before (125)I permanent seed implantation
Number of subjects: 165

Group type: COMPARATOR
Intervention: (125)I permanent seed implantation
Number of subjects: 165
Study: 21067382

Group type: EXPERIMENTAL
Intervention: Casein hydrolysate formula
Number of subjects: 230

Group type: COMPARATOR
Intervention: Conventional, cow's‐milk‐based formula (control)
Number of subjects: 230
Study: 17579840

Group type: EXPERIMENTAL
Intervention: ropinirole 0.5 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: ropinirole 0.25 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study: 15956965

Group type: EXPERIMENTAL
Intervention: ZD4054 (single oral dose)
Number of subjects: 36

Group type: COMPARATOR
Intervention: ZD4054 (ascending single-dose)
Number of subjects: 36
Study: 11860422

Group type: EXPERIMENTAL
Intervention: Diamond laser scalpel combined with CO2 laser
Number of subjects: 10

Group type: COMPARATOR
Intervention: Free beam CO2 laser
Number of subjects: 10
Study: 10432325

Group type: EXPERIMENTAL
Intervention: Cefotaxime plus intravenous albumin
Number of subjects: 126

Group type: COMPARATOR
Intervention: Cefotaxime
Number of subjects: 126
Study: 8560415

Group type: EXPERIMENTAL
Intervention: Desmopressin
Number of subjects: 1171

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1171
Study: 2265052

Group type: EXPERIMENTAL
Intervention: Leg wrapping with elasticated Esmarch bandages
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (no leg wrapping)
Number of subjects: 24
Study: 7437242

Group type: EXPERIMENTAL
Intervention: Indacrinone (MK-196) 60 mg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Indacrinone (MK-196) 40 mg
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Indacrinone (MK-196)
Number of subjects: 15
Study: 31860107

Group type: EXPERIMENTAL
Intervention: Concept group (explicit conceptual instruction regarding diagnostic testing and bayesian revision)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Experience group (exposure to repeated examples of cases with feedback regarding posttest probability)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (no conceptual instruction or repeated examples)
Number of subjects: 61
Study: 28539065

Group type: EXPERIMENTAL
Intervention: Cartoon-style handout
Number of subjects: 93

Group type: COMPARATOR
Intervention: Traditional-style handout
Number of subjects: 93
Study: 24922198

Group type: EXPERIMENTAL
Intervention: Ivabradine
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Beta-blocker
Number of subjects: 58
Study: 24302273

Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 839

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 839
Study: 22198243

Group type: EXPERIMENTAL
Intervention: CA-125 velocity (average velocity of 19.749 U/ml per month)
Number of subjects: 28038

Group type: COMPARATOR
Intervention: Non-cancer group (average velocity of 0.035 U/ml per month)
Number of subjects: 28038

Group type: EXPERIMENTAL
Intervention: CA-125 velocity and time intervals between screenings
Number of subjects: 28038
Study: 18923870

Group type: EXPERIMENTAL
Intervention: Lightweight polypropylene mesh
Number of subjects: 25

Group type: COMPARATOR
Intervention: Heavy polypropylene mesh
Number of subjects: 25
Study: 17889549

Group type: EXPERIMENTAL
Intervention: Oral and Maxillofacial Surgery (OMFS) patients
Number of subjects: 600

Group type: COMPARATOR
Intervention: Control groups (surgical, dental, and general practitioners/internal medicine patients)
Number of subjects: 600
Study: 15241768

Group type: EXPERIMENTAL
Intervention: Wheelchair Skills Training Program (WSTP)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Standard undergraduate OT curriculum (Control)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Fourth-year control group
Number of subjects: 82
Study: 12568207

Group type: EXPERIMENTAL
Intervention: Enalapril 10 mg/day
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Nifedipine 30 mg/day
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 30
Study: 9884181

Group type: EXPERIMENTAL
Intervention: St. John's wort
Number of subjects: 0
Study: 10670264

Group type: EXPERIMENTAL
Intervention: 0.1 mg subarachnoid morphine with bupivacaine (group M)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (group S)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study: 1381642

Group type: EXPERIMENTAL
Intervention: Teicoplanin (single bolus intravenous injection before catheter insertion)
Number of subjects: 88

Group type: COMPARATOR
Intervention: No teicoplanin (control group)
Number of subjects: 88
Study: 6885575

Group type: EXPERIMENTAL
Intervention: Metabolic acidosis (induced by ammonium chloride)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Respiratory acidosis (induced by 5% CO2 inhalation)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo (control study)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Metabolic alkalosis (induced by sodium bicarbonate)
Number of subjects: 6
Study: 31390774

Group type: EXPERIMENTAL
Intervention: Frequency Ratio (FR) method
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Information Value Model (IVM) method
Number of subjects: 71
Study: 29777144

Group type: EXPERIMENTAL
Intervention: General anesthesia associated with SAM block + PECS I
Number of subjects: 50

Group type: COMPARATOR
Intervention: General anesthesia only
Number of subjects: 50
Study: 26817639

Group type: EXPERIMENTAL
Intervention: School-based intervention promoting HPV vaccination and condom use, delivered by school nurses in a 30 min face-to-face structured session.
Number of subjects: 741
Study: 24735128

Group type: EXPERIMENTAL
Intervention: 360 μg budesonide
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 720 μg budesonide
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 1,440 μg budesonide
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: four repetitive 720-μg budesonide doses
Number of subjects: 20

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20